EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Real-World Treatment Patterns and Clinical Outcomes with Cyclosporine 0.1% in Semifluorinated Alkane for Dry Eye Disease

Alice T Epitropoulos iD, Soham J Barot, Richard L Lindstrom, Richard Costine

Clinical Ophthalmology · 2026-08 · Volume 20 · 1-9

DOI: 10.2147/opth.s623242 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Ophthalmology, 2026-08. Verfasst von Alice T Epitropoulos und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Central Ohio Eye and Plastic Surgery, Columbus, OH, USA. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

SPEED questionnairecorneal stainingcyclosporinedry eye diseaseperfluorobutylpentanereal-world evidencesemifluorinated alkane

Autor:innen und Institutionen

  • Department of Ophthalmology, Central Ohio Eye and Plastic Surgery, Columbus, OH, USA.
  • Department of Ophthalmology, The Eye Center of Columbus, Columbus, OH, USA.
  • Department of Ophthalmology, Minnesota Eye Consultants, Blaine, MN, USA.
  • Medical Affairs, Harrow Inc, Nashville, TN, USA.

ORCID-Profile: Alice T Epitropoulos

Zitieren

APA

Epitropoulos, A. T., Barot, S. J., Lindstrom, R. L., & Costine, R. (2026). Real-World Treatment Patterns and Clinical Outcomes with Cyclosporine 0.1% in Semifluorinated Alkane for Dry Eye Disease. Clinical Ophthalmology, Volume 20, 1-9. https://doi.org/10.2147/opth.s623242

Vancouver

Epitropoulos AT, Barot SJ, Lindstrom RL, Costine R. Real-World Treatment Patterns and Clinical Outcomes with Cyclosporine 0.1% in Semifluorinated Alkane for Dry Eye Disease. Clinical Ophthalmology. 2026;Volume 20:1-9. doi:10.2147/opth.s623242

BibTeX
@article{Epitropoulos2026,
  author = {Epitropoulos, Alice T and Barot, Soham J and Lindstrom, Richard L and Costine, Richard},
  title = {Real-World Treatment Patterns and Clinical Outcomes with Cyclosporine 0.1% in Semifluorinated Alkane for Dry Eye Disease},
  journal = {Clinical Ophthalmology},
  year = {2026},
  volume = {Volume 20},
  pages = {1--9},
  doi = {10.2147/opth.s623242}
}
Kostenlos starten →